MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Mobile Brain / Body Imaging in early Parkinson’s Disease: the Twin Brain project

    M. Ajcevic, A. Buoite Stella, A. Miladinovic, M. Peskar, M. Kalc, T. Lombardo, M. Deodato, M. Catalan, U. Marusic, P. Manganotti (Trieste, Italy)

    Objective: We aimed to setup a novel Mobile Brain / Body Imaging (MoBI) system and to perform a feasibility study for the future investigations of…
  • 2023 International Congress

    Effectiveness of at home, repeated transcranial pulse current stimulation (tPCS) sessions for treatment of neurodegenerative ataxia.

    G. Prado- Miranda, D. Aur, D. Babiker, M. Jog (London, On, Canada)

    Objective: To investigate whether a 2-week treatment with anodal cerebellar and cathodal spinal transcranial pulse current stimulation (tPCS) can improve symptoms in neurodegenerative ataxia at…
  • 2023 International Congress

    Impact of the COVID-19 pandemic on DBS accessibility: a single center experience

    F. Sarmento, S. Aghili-Mehrizi, T. de Araujo, J. Wong (Gainesville, USA)

    Objective: To evaluate the impact of the COVID-19 pandemic on accessibility to deep brain stimulation (DBS) care at a tertiary DBS center Background: Early responses…
  • 2023 International Congress

    Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson’s Disease

    J. Mack, L. Marsh, A. Sarwar, K. Rodriguez, A. King, M. Hinojosa-Lindsey, R. Miller, L. ST. Hill, S. O'Connor, K. Ketchum, M. Latorre, A. Interian, R. Dobkin (Portland, USA)

    Objective: To describe the ongoing implementation and expansion of a telehealth psychotherapy hub to treat depression in rural Veterans with PD. Background: Depression is common…
  • 2023 International Congress

    Case Report: Supranuclear Palsy and Increased Intraocular Pressure in Normal Pressure Hydrocephalus

    K. Young, M. Gates (Austell, USA)

    Objective: . Background: Normal pressure hydrocephalus (NPH) is characterized by a triad of symptoms: gait abnormality, urinary incontinence (UI) and cognitive decline.  Though clinical findings…
  • 2023 International Congress

    Natural history and disease progression biomarkers of multiple system atrophy: the ASPIRE-MSA study

    N. Del Campo, P. Péran, P. Payoux, V. Rousseau, A. Drif, H. Catalá, C. Thalamas, C. Tranchant, F. Duriff, A. Marques, JP. Azulay, C. Moreau, JC. Corvol, S. Thobois, AG. Corbille, S. Frismand, B. Patterson, A. Foubert-Samier, A. Pavy-Letraon, M. Fabbri, W. Meissner, O. Rascol (Toulouse, France)

    Objective: To evaluate multiple system atrophy (MSA) disease progression on a panel of candidate MSA biomarkers pre-selected for their putative involvement in the pathophysiology of…
  • 2023 International Congress

    Free water neuro-imaging changes as the biomarker in new diagnosis of Wilson’s disease

    XP. Wang, XZ. Jing (Shanghai, China)

    Objective: The bi-tensor free water imaging may provide more specific information in detecting microstructural brain tissue alterations than conventional single tensor diffusion tensor imaging. The…
  • 2023 International Congress

    High Intensity Interval Training for people with Parkinson’s disease: individual response patterns of (non-)motor symptoms and blood-based biomarkers – a crossover single-case experimental design

    E. van Wegen, E. Amaral-Gomez, M. Rietberg, V. de Groot, M. Hirsch, T. Vanbellingen, W. Vanden Berg, O. Vanden Heuvel, C. Vriend (Amsterdam, Netherlands)

    Objective: To quantify individual response patterns of motor symptoms to alternating exercise modalities, along non-motor functioning and blood biomarkers of neuroplasticity and neurodegeneration. Background: Physical…
  • 2023 International Congress

    Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial

    D. Kern, S. Isaacson, S. Dhanani, J. Aldred, B. Bergmans, D. Santos-Garcia, T. Oeda, F. Gandor, P. Kukreja, L. Bergmann, R. Gupta, S. Talapala, A. Spiegel, T. Kimber (Aurora, USA)

    Objective: Evaluate the frequency of adverse events over time with foslevodopa/foscarbidopa (LDP/CDP) in patients with advanced Parkinson’s disease (PD) in a phase 3, open-label safety…
  • 2023 International Congress

    Reproductive life factors and sex hormones in post-menopausal female patients with Parkinson’s Disease

    R. Bovenzi, M. Conti, G. Sancesario, R. Cerroni, M. Pierantozzi, A. Stefani, N. Mercuri, T. Schirinzi (Rome, Italy)

    Objective: To deepen into sex-dependent mechanisms of Parkinson’s disease (PD) by analyzing the relationships between reproductive life factors, sex hormones, clinical features, and CSF biomarkers…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley